Company profile: WestBred
1.1 - Company Overview
Company description
- Provider of highest yield potential wheat seed designed for regional conditions, including certified single-variety seed containing no other crops, foreign material, or certain seed-borne diseases; Clearfield Plus production system for grass and broadleaf weed control using Beyond herbicide; grower resources such as optimal seeding rate guidance; intellectual property protection for varieties; and the National Wheat Yield Contest.
Products and services
- Clearfield Plus Production System: Field-scale, conventionally bred system that produces broad-spectrum grass and broadleaf weed control in wheat using Beyond herbicide
- Certified Seed: Inspection-validated, certified-grade wheat of a single variety that passes official inspection and contains no other crops, foreign material, or certain seed-borne diseases
- Optimal Seeding Rate: Agronomy-guided planting recommendations specifying optimal wheat seeding rates to avert underseeding or overseeding that can diminish yield and profit potential
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to WestBred
Synlab
HQ: Germany
Website
- Description: Provider of laboratory diagnostics for human and veterinary medicine and environmental analysis services. Delivers wide-ranging laboratory testing, specialty and genetic testing (including preimplantation), supported by 2,000+ medical experts across 30+ countries and 2,000+ blood collection points. Also focuses on medical supplies trade, clinical trials, and consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synlab company profile →
Feldan Therapeutics
HQ: Canada
Website
- Description: Provider of a patented peptide-based technology platform for delivering therapeutic compounds into cells, including the Feldan Shuttle, and FLD-103, an intralesional treatment for basal cell carcinoma that targets BCC cells by disrupting an intracellular component involved in the disease’s pathophysiology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Feldan Therapeutics company profile →
Castle Biosciences
HQ: United States
Website
- Description: Provider of molecular and genomic diagnostic tests for cancer, including DecisionDx-Melanoma for risk of recurrence, metastasis and sentinel lymph node positivity in cutaneous melanoma; DecisionDx-SCC for nodal or distant metastasis risk in SCC; TissueCypher to predict progression to esophageal cancer in Barrett’s esophagus; DecisionDx-UM for metastatic risk in uveal melanoma; and IDgenetix to guide personalized mental health medication selection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Castle Biosciences company profile →
Strata Oncology
HQ: United States
Website
- Description: Provider of precision oncology solutions, including Strata Select, a DNA/RNA-based molecular profiling test guiding immunotherapy and other treatment selection for advanced cancer; the Immunotherapy Response Score predicting benefit of anti-PD-1/PD-L1 monotherapy; and clinical trials such as Strata PATH and Strata Trial enabling biomarker-guided evaluation and access to approved and investigational therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Strata Oncology company profile →
Enancio
HQ: France
Website
- Description: Provider of high-speed, efficient genomic data compression and decompression, complementing Illumina’s other informatics solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enancio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for WestBred
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to WestBred
2.2 - Growth funds investing in similar companies to WestBred
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for WestBred
4.2 - Public trading comparable groups for WestBred
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →